DAL vs NBIX · P/E 12, rev $61.64B vs P/E 45, rev $2.36B
Delta Air Lines Inc (DAL) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DAL and NBIX stock pages for the full models.
Not investment advice.